ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 766

Anemia May Provide Clinically Relevant Information Beyond Conventional Disease Activity Assessment to Predict Radiographic Damage Progression in Rheumatoid Arthritis

Burkhard Moller1, Frauke Förger2, Peter M. Villiger3 and Axel Finckh4, 1Rheumatology, Inselspital University Hospital, Bern, Switzerland, 2Rheumatology, Clinical Immunology and Allergology, Inselspital University Hospital of Bern, Bern, Switzerland, 3Rheumatology, Immunology and Allergology, University Hospital Bern, Bern, Switzerland, 4Rheumatology, Geneva University Hospitals, Geneva 14, Switzerland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Anemia, radiography and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Risk Factors and Prediction of Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Anemia may provide clinically relevant information beyond conventional disease activity assessment to predict radiographic damage progression in Rheumatoid Arthritis

Burkhard Möller, Frauke Förger, Peter M. Villiger, Axel Finckh, on behalf of the Swiss Clinical Quality Management Program for Rheumatic Diseases.

Background/Purpose: Anemia in rheumatoid arthritis (RA) is prototypic for anemia of chronic disease (ACD) and often neglected in clinical practice. Previous studies have shown a relation between this extra-articular manifestation of RA and disease severity. Purpose: To study the relation between anemia and radiographic progression in RA.

Methods: This study is nested in a large prospective RA patient cohort. Data were collected between 1996 and 2007. Anemia was defined according to the WHO criteria (♀ Hb<12, ♂: Hb<13 g/dl). We also used one less (♀ Hb<12.2, ♂ 20-59y: Hb<13.7 g/dl, ♂ 60+y: Hb<13.2 g/dl) and one more severe definition of anemia (♀ Hb<11, ♂: Hb<12 g/dl) in sensitivity analyses. Erosions were assessed with a validated erosion score (Ratingen score) of 38 joints at hands and feet in 11255 radiograph sets from 4005 RA patients, over a mean follow-up of 2.2 years. Radiographic progression was analyzed using longitudinal regression models for repeated data and adjusted for potential confounding factors, such as age, gender, rheumatoid factor, disease duration and erosion score at inclusion, baseline and time dependent DAS28ESR, DMARD, glucocorticoid and anti-TNF therapy. Subgroup analyses were performed in patients starting on methotrexate (n=728) or anti-TNF-therapy (n=938), in patients achieving different stages of severe, moderate, mild disease activity or remission (DAS28ESR<2.6, n=1253) at the final visit, and in 508 patients achieving remission after TNF blockade.

Results: Erosions progressed significantly (p<0.001) faster in patients with than without anemia, despite adjusting for clinical disease activity and other important predictors of joint damage. As an example, erosion had progressed by mean 1.36% (95% CI 1.21-1.51) in non-anemic versus 2.66% (2.17-3.14) in anemic patients after one year. Patients with less severe anemia had a less rapid and patients with more severe anemia displayed a more rapid joint damage progression, suggesting a ‘dose response effect'. Effect modification by anemia went insignificant in subgroups of patients with persistent clinically detectable disease activity, but remained a significant factor for more rapid erosive progression in patients achieving remission upon any treatment (p<0.001) or upon anti-TNF-therapy (p<0.001).

Conclusion: Anemia appears to capture structural disease processes that remain unmeasured by conventional disease activity measures in patients with or without TNF blockade. Thus, anemia may help to identify patients with more rapid erosive disease.


Disclosure:

B. Moller,
None;

F. Förger,
None;

P. M. Villiger,
None;

A. Finckh,

Roche, Pfizer, BMS,

2,

Roche, Pfizer, BMS,

5.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anemia-may-provide-clinically-relevant-information-beyond-conventional-disease-activity-assessment-to-predict-radiographic-damage-progression-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology